You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
14 December 2021
sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma
23 November 2021
sterna biologicals GmbH & Co. KG: STERNA BIOLOGICALS RECEIVES APPROVAL FOR INNOVATIVE PHASE II A STUDY DESIGN IN ASTHMA COMBINING A NOVEL ANTISENSE-BASED TREATMENT WITH A DIGITAL THERAPY
7 January 2021
sterna biologicals GmbH & Co. KG raises further EUR 10.0 million (approx. USD 11.9 million) in Series A – 2nd closing private placement
26 May 2020
Sterna biologicals secures EUR 12.0 million (approx. USD 13.0 million) in private placement
7 November 2019
Sterna biologicals to attend international partnering and investor conferences in November
25 July 2019
sterna biologicals invited to present at the Goodwin – Solebury Trout – NASDAQ European Biotech Investor Day 2019